NRG LU003

Primary Category:

Treatment Protocols

Disease Category:

Lung, Lung - Non-Small Cell, Lung - Non-Small Cell Metastatic

Status:

Open

A Biomarker-Driven Protocol for Previously Treated ALK-Positive Non-Squamous NSCLC Patients: The NCI-NRG ALK Master Protocol

NCT#03737994

Treatment consent forms for individual agents for this study are available upon request when a patient at your site is assigned to a study agent.  Please contact Jodi Fischer, jfischer@mtcancer.org or 406-969-6068, for the consents & for any questions.